Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Top Cited Papers
- 1 September 2009
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 27 (25), 4150-4154
- https://doi.org/10.1200/jco.2009.21.9832
Abstract
Purpose Unexpected mutations affecting the isocitrate dehydrogenase (IDH1) gene at codon 132 have been found in 12% of glioblastomas. Patients and Methods IDH1 codon 132 sequencing was performed in...Keywords
This publication has 13 references indexed in Scilit:
- Analysis of the IDH1 codon 132 mutation in brain tumorsActa Neuropathologica, 2008
- p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiationNature, 2008
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomasInternational Journal of Cancer, 2007
- Tumor genomic profiling and TP53 germline mutation analysis of first-degree relative familial gliomasCancer Genetics and Cytogenetics, 2007
- Genetic Pathways to Primary and Secondary GlioblastomaThe American Journal of Pathology, 2007
- MGMT methylation: A marker of response to temozolomide in low‐grade gliomasAnnals of Neurology, 2006
- Inactivation of the DNA-Repair GeneMGMTand the Clinical Response of Gliomas to Alkylating AgentsNew England Journal of Medicine, 2000
- Expression and Mutagenesis of Mammalian Cytosolic NADP+-Specific Isocitrate DehydrogenaseBiochemistry, 1997